Women’s Health
Now there’s a money spinner! <<<Health>>>
I’m not surprised they’re reticent! Look up Collins paper in Nature a few weeks ago – brilliant stats assessment of IP-Mass Spec to measure amyloid in PET scans and CSF samples And it’s a very accuratealternative to CSF sampling I do wonder if it’s commercially viable thought (I don’t know enough about IP-MS) <<<AD Risk […]
Thank god for Statisticians – I hate it when clinicians refer to single cases At least there is a big follow up survey And this isn’t rocket science either! <<<DIET>>>
Now this is fascinating – Apple trying to match medical records with subjects on smartphones Would this mean we could do the ultimate in virtual trials Recruit patients from iPhone database, import history data, order and provide medication electronically, prompt patients to take meds and to record ePRO data and even record automically vital signs. […]
This time it’s Takeda’s turn with pioglitazone (repurposing diabetic treatment) in Phase III <<<AD Failure>>>
Just shows you the value of ‘weight of evidence’ ie numbers of subjects >>>Depression Meta Analysis<<<
Obviously these guys aren’t sportsmen! Just showing you can extend endurance doesn’t improve fitness We had a soluble glucuronic acid did the same thing Preferentially burning fat may be useful treatment in obesity <<<LINK>>>
Apparently the MHRA is may consider developing links with the FDA post Brexit now the the EMA will move out of London The aim would be to have agreement in place to allow fast track approvals. Now that would be interesting >>> http://www.thetimes.co.uk/edition/business/britain-eyes-american-drug-approval-pact-0mwrj7g6f
Keith’s CogTrack finds some interesting effects on short/long term memory and speed of retrieval >>> Study: Red Bull energy drink boosts memory performance
This time Merck’s BACE inhibitor of amyloid beta >> http://www.pharmatimes.com/news/merck_pulls_plug_on_late-stage_alzheimers_trial_1186737?utm_source=PT+Daily+Newsletter&utm_medium=email&utm_campaign=pt+daily+news+alert